+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Monoclonal Antibody Diagnostic Reagent Market: Analysis By Tests, By Application, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028

  • PDF Icon

    Report

  • 141 Pages
  • September 2023
  • Region: Global
  • Daedal Research
  • ID: 5880782

Monoclonal Antibody Diagnostic Reagents are reagents that use monoclonal antibodies as active components to identify infectious pathogens, aberrant cells, or parts of the body's reaction to sickness. In 2022, the global monoclonal antibody diagnostic reagent market was valued at US$8.85 billion, and is probable to reach US$18.63 billion by 2028.

The market is also expected to boost in the future as a robust pipeline of monoclonal antibody therapeutics is being developed for the treatment of a wide range of ailments, including cancer, autoimmune disorders, and infectious diseases. Furthermore, significant technological advances have been made in the synthesis and purification of monoclonal antibodies. This has reduced the cost and availability of monoclonal antibody diagnostic reagents while also broadening their applications. The global monoclonal antibody diagnostic reagent market value is projected to grow at a CAGR of 13.25%, during the forecast period of 2023-2028.

Market Segmentation Analysis:

  • By Tests: According to the report, the global monoclonal antibody diagnostic reagent market is segmented into four tests: Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Assay Recombinant Immunoblot and Dot-immunogold Filtration Assay. Enzyme Linked Immunosorbent segment acquired majority of share in the market in 2022, because this test is a popular biochemical technique for identifying specific proteins, antibodies, antigens, or other compounds in biological samples. Whereas, the same segment has the fastest CAGR due to the increasing prevalence of chronic diseases, such as cancer, infectious diseases, and autoimmune disorders, which can be diagnosed and monitored using ELISA tests.
  • By Application: According to the report, the global monoclonal antibody diagnostic reagent market is segmented into four applications: Tumor Monitoring, Virus Detection, Hormones Diagnosis and Others. Tumor Monitoring segment acquired majority of share in the market in 2022 as they can be used to detect tumor markers, image tumors, and target tumors for therapy. This can help to improve the diagnosis, treatment, and monitoring of cancer. Whereas, virus detection segment has the fastest CAGR because monoclonal antibodies are highly specific to their target antigens, which means that they can be used to detect very small amounts of the antigen. This is important for virus detection, as viruses are often present in low levels in the body.
  • By Region: The report provides insight into the monoclonal antibody diagnostic reagent market based on the geographical operations, namely North America, Europe, Asia Pacific, and Rest of the World. North America monoclonal antibody diagnostic reagent market enjoyed the highest market share in 2022, due to rising R&D spending by businesses and government funding for cancer research has facilitated the development of innovative monoclonal antibody treatments.
  • The US, has one of the highest healthcare spending rates globally. This substantial investment in healthcare infrastructure has driven the adoption of advanced diagnostic technologies, including monoclonal antibody-based diagnostic reagents.
  • Further, Asia Pacific monoclonal antibody diagnostic reagent is expected to grow at the fastest CAGR due to governments and private organizations in the region are investing heavily in healthcare. This is leading to the development of new diagnostic facilities and the adoption of new technologies, such as monoclonal antibody diagnostic reagents.

Global Monoclonal Antibody Diagnostic Reagent Market Dynamics:

  • Growth Drivers: Monoclonal antibody diagnostic reagents aid in the early identification and accurate diagnosis of many cancers. Early detection is crucial because it enables timely intervention and potentially life-saving therapy. Monoclonal antibodies are particularly designed to target cancer-related antigens or biomarkers found in patient samples such as blood, tissue, or urine. Further, the market is expected to increase due to aging population, amplified disposable income, growing healthcare expenditure, growth in investments in biotech companies, extensive R&D efforts to develop novel therapies, etc.
  • Challenges: The market's expansion is projected to be hampered by high cost. This pricing barrier affects many areas of monoclonal antibody-based diagnostics, including accessibility, affordability, and sustainability. Monoclonal antibody diagnostic reagents are typically more expensive than other types of diagnostic reagents. The other challenges that monoclonal antibody diagnostic reagent market faces include limited availability.
  • Trends: One of the most distinct and pervasive trends observed in the global monoclonal antibody diagnostic reagent market is increasing availability of point-of-care testing (POCT). Point-of-care testing (POCT) allows for the testing of patients at the point of care, such as in doctor's offices or clinics. This is convenient for patients and can help to improve patient outcomes. Monoclonal antibody diagnostic reagents are well-suited for POCT applications. POCT is emerging as a significant trend in the monoclonal antibody diagnostic reagent market. More trends in the market are believed to augment the growth of monoclonal antibody diagnostic reagent market during the forecasted period include, growing use of multiplexed assays, technological advancements and development of new monoclonal antibody-based therapies, etc.

Impact Analysis of COVID-19 and Way Forward:

The COVID-19 pandemic has a positive impact on the global market because the pandemic has had a significant impact on the discovery, manufacture, and use of monoclonal antibody diagnostic reagents. Several monoclonal antibody diagnostic reagents have been developed for COVID-19. These reagents are being used in clinical trials and are expected to be available for widespread use in the near future. The pandemic has also led to increased funding for research and development of monoclonal antibody diagnostic reagents. The impact of COVID-19 on the market is likely to be long-lasting.

Competitive Landscape and Recent Developments:

Global monoclonal antibody diagnostic reagent market is fragmented. Key players of global monoclonal antibody diagnostic reagent market are:

  • Becton, Dickinson and Company (BD Biosciences)
  • Merck & Co., Inc.
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Abcam Plc., (BioVision)
  • Innovent Biologics, Inc.
  • Celltrion, Inc.
  • Eurogentec (AnaSpec)
  • BioGenex
  • Biocare Medical LLC
  • Aviva Systems Biology
  • Medix Biochemica
  • Creative Diagnostics
  • Cell Signaling Technology

The key players are constantly investing in strategic initiatives, such as new product launches, introducing their products to emerging markets and more, to maintain a competitive edge in this market. For instance, in January 2022, Ono Pharmaceutical Co., Ltd. Collaborated with Neuroimmune AG to develop the mAb drug against novel therapeutic targets for neurodegenerative diseases.

Table of Contents


1. Executive Summary
2. Introduction
2.1 Monoclonal Antibody Diagnostic Reagent: An Overview
2.1.1 Monoclonal Antibodies Used To Treat
2.2 Monoclonal Antibody Diagnostic Reagent Segmentation: An Overview
2.2.1 Monoclonal Antibody Diagnostic Reagent Segmentation
3. Global Market Analysis
3.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Analysis
3.1.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Overview
3.1.2 Global Monoclonal Antibody Diagnostic Reagent Market by Value
3.1.3 Global Monoclonal Antibody Diagnostic Reagent Market by Test (Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Assay Recombinant Immunoblot and Dot-immunogold Filtration Assay)
3.1.4 Global Monoclonal Antibody Diagnostic Reagent Market by Application (Tumor Monitoring, Virus Detection, Hormones Diagnosis and Others)
3.1.5 Global Monoclonal Antibody Diagnostic Reagent Market by Region (North America, Europe, Asia Pacific and Rest of the World)
3.2 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Analysis
3.2.1 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Overview
3.2.2 Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value
3.2.3 Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value
3.2.4 Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value
3.2.5 Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value
3.3 Global Monoclonal Antibody Diagnostic Reagent Market: Application Analysis
3.3.1 Global Monoclonal Antibody Diagnostic Reagent Market: Application Overview
3.3.2 Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value
3.3.3 Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value
3.3.4 Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value
3.3.5 Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value
4. Regional Market Analysis
4.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Analysis
4.1.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.1.2 North America Monoclonal Antibody Diagnostic Reagent Market by Value
4.1.3 North America Monoclonal Antibody Diagnostic Reagent Market by Region (The US, Canada and Mexico)
4.1.4 The US Monoclonal Antibody Diagnostic Reagent Market by Value
4.1.5 Canada Monoclonal Antibody Diagnostic Reagent Market by Value
4.1.6 Mexico Monoclonal Antibody Diagnostic Reagent Market by Value
4.2 Europe Monoclonal Antibody Diagnostic Reagent Market: An Analysis
4.2.1 Europe Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.2.2 Europe Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.3 Europe Monoclonal Antibody Diagnostic Reagent Market by Region (Germany, UK, France, Italy, Spain, and Rest of Europe)
4.2.4 Germany Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.5 UK Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.6 France Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.7 Italy Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.8 Spain Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.9 Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value
4.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Analysis
4.3.1 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.3.2 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
4.3.4 China Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.5 Japan Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.6 India Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.7 South Korea Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.8 Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value
4.4 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Analysis
4.4.1 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.4.2 Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Monoclonal Antibody Diagnostic Reagent
5.1.2 Post COVID-19 Impact
6. Market Dynamics
6.1 Growth Driver
6.1.1 Escalating Incidence of New Cancer Cases
6.1.2 Aging Population
6.1.3 Amplified Disposable Income
6.1.4 Growing Healthcare Expenditure
6.1.5 Growth in Investments in Biotech Companies
6.1.6 Extensive R&D Efforts to Develop Novel Therapies
6.2 Challenges
6.2.1 High Cost
6.2.2 Limited Availability
6.3 Market Trends
6.3.1 Increasing Availability of Point-of-care Testing (POCT)
6.3.2 Growing Use of Multiplexed Assays
6.3.3 Technological Advancements
6.3.4 Development Of New Monoclonal Antibody-based Therapies
7. Competitive Landscape
7.1 Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison
8. Company Profiles
8.1 Becton, Dickinson and Company (BD Biosciences)
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Merck & Co., Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies
8.3 Qiagen
8.3.1 Business Overview
8.3.2 Operating Regions
8.3.3 Business Strategy
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy
8.5 Abcam Plc., (BioVision)
8.5.1 Business Overview
8.5.2 Operating Regions
8.5.3 Business Strategy
8.6 Innovent Biologics, Inc.
8.6.1 Business Overview
8.6.2 Operating Regions
8.6.3 Business Strategy
8.7 Celltrion, Inc.
8.7.1 Business Overview
8.7.2 Operating Segments
8.8 Eurogentec (AnaSpec)
8.8.1 Business Overview
8.8.2 Business Strategy
8.9 BioGenex
8.9.1 Business Overview
8.9.2 Business Strategy
8.10 Biocare Medical LLC
8.10.1 Business Overview
8.10.2 Business Strategy
8.11 Aviva Systems Biology
8.11.1 Business Overview
8.11.2 Business Strategy
8.12 Medix Biochemica
8.12.1 Business Overview
8.12.2 Business Strategy
8.13 Creative Diagnostics
8.13.1 Business Overview
8.14 Cell Signaling Technology
8.14.1 Business Overview
List of Figures
Figure 1: Monoclonal Antibodies Used To Treat
Figure 2: Monoclonal Antibody Diagnostic Reagent Segmentation
Figure 3: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 5: Global Monoclonal Antibody Diagnostic Reagent Market by Test; 2022 (Percentage, %)
Figure 6: Global Monoclonal Antibody Diagnostic Reagent Market by Application; 2022 (Percentage, %)
Figure 7: Global Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 8: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 9: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 10: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 11: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 12: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 13: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 14: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 15: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 16: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 17: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 18: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 19: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 20: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 21: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 22: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 23: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 24: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 25: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 26: North America Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 27: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 28: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 29: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 30: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 31: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 32: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 33: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 34: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 35: Europe Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 36: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 37: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 38: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 39: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 40: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 41: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 42: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 43: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 44: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 45: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 46: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 47: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 48: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 49: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 50: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 51: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 52: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 53: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 54: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 55: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 56: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 57: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 58: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 59: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 60: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 61: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 62: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 63: The US Estimated Numbers of New Cancer Cases; 2017-2023 (Million)
Figure 64: Global Percentage of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 65: Global GNI per Capita; 2016-2022 (Thousand)
Figure 66: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
Figure 67: Becton, Dickinson and Company Revenue by Segment; 2022 (Percentage, %)
Figure 68: Merck & Co., Inc. Sales by Segments; 2022 (Percentage, %)
Figure 69: Qiagen Net Sales by Regions; 2022 (Percentage, %)
Figure 70: Bio-Rad Laboratories, Inc. Net Sales by Segments; 2022 (Percentage, %)
Figure 71: Abcam Plc. Revenue by Regions; 2022 (Percentage, %)
Figure 72: Innovent Biologics, Inc. Revenue by Regions; 2022 (Percentage, %)
Figure 73: Celltrion, Inc. Revenue by Segments; 2022 (Percentage, %)
Table 1: Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison; 2023

Companies Mentioned

  • Becton, Dickinson and Company (BD Biosciences)
  • Merck & Co., Inc.
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Abcam Plc., (BioVision)
  • Innovent Biologics, Inc.
  • Celltrion, Inc.
  • Eurogentec (AnaSpec)
  • BioGenex
  • Biocare Medical LLC
  • Aviva Systems Biology
  • Medix Biochemica
  • Creative Diagnostics
  • Cell Signaling Technology

Methodology

Loading
LOADING...